Is a THA Stem in Varus a Risk Factor of Long-term Mechanical Complication (PTHVarus)

June 29, 2022 updated by: University Hospital, Brest
The objective of this study is to compare the long-term survival as well as the functional and radiographic results of the rods in the alignment of the varus to the stems in the neutral alignment by comparing 2 groups of implanted Total Hip Arthroplasty. 1 group of stems implanted in varus position. 1 group of stems implanted in neutral position

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

ABSTRACT:

Introduction: Femoral stem positioning in the frontal plane has always been considered a fundamental criterion for implant survival and for functional and radiographic outcomes in total hip arthroplasty (THA). The impact of implanting cementless femoral stems in varus alignment on long-term mechanical complications remains poorly defined in the literature. The aim of our study is to compare long-term survivorship as well as functional and radiographic outcomes of stems in varus alignment to stems in neutral alignment.

Patients and Methods: This single center, multi-surgeon, retrospective case-control study will compare a group of 105 THA patients with varus stem alignment (VS) to a control group of 105 THA patients with neutral stem alignment (NS), operated in Brest center between January 2007 and December 2012. The primary outcome measure is implant survival. Secondary outcomes include functional outcomes: HHS, PMA, thigh pain, dislocation and hip ROM; and radiographic outcomes: radiolucency, Agora Roentgenography Assessment (ARA) score, osseointegration, heterotopic ossification, subsidence and stress shielding.

Study Type

Observational

Enrollment (Actual)

210

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brest, France, 29609
        • Chu de Brest

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients who received a first-line PTH between 2007 and 2012,

Description

Inclusion Criteria:

  • PTH rod implanted in varus,
  • Having X-rays and clinical data in their file
  • Within a period of less than 6 months
  • No opposition

Exclusion Criteria:

  • PTH in a context of fracture of the femoral neck
  • PTH 2nd intention
  • Lost to sight
  • Patients who died within 6 months
  • Refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Varus Stems
Patients with a THA Stem implanted in Varus position
Patient were operated, a Total hip arthroplasty was performed
Neutral stems
Patients with a THA Stem implanted in Neutral position
Patient were operated, a Total hip arthroplasty was performed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survival rate
Time Frame: It was measured in October 2021
The main outcome measured was the survival of the implant
It was measured in October 2021

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HHS
Time Frame: It was measured in October 2021
Functional outcome : - The Harris Hip Score (HHS) [26] which assesses pain, function, deformity and range of motion (ROM) with a maximum score of 100
It was measured in October 2021
PMA score :
Time Frame: It was measured in October 2021
Functional outcome : which assesses pain, gait and mobility with a maximum score of 18
It was measured in October 2021
Thigh pain
Time Frame: It was measured in October 2021
Functional outcome : we measured the rate of patients experiencing pain at the level of the thigh
It was measured in October 2021
Dislocation
Time Frame: It was measured in October 2021
Functional outcome : hip disclocation rate over the follow up period
It was measured in October 2021
Hip ROM
Time Frame: It was measured in October 2021
Functional outcome : Hip range of motion in flexion, adduction, extension, abduction and rotations
It was measured in October 2021
Radiolucency
Time Frame: It was measured in October 2021
Radiographic outcome : - Radiolucency according to the Gruen/Callaghan zones
It was measured in October 2021
Agora Roentgenography Assessment (ARA) score
Time Frame: It was measured in October 2021
Radiographic outcome : - Agora Roentgenography Assessment (ARA) score for cementless femoral stem stability according to Epinette
It was measured in October 2021
Osseointegration
Time Frame: It was measured in October 2021
Radiographic outcome mesured was described in "Roentgenographic assessment of the biologic fixation of porous-surfaced femoral components" Engh CA, Massin P, Suthers KE"
It was measured in October 2021
Heterotopic ossification
Time Frame: t was measured in October 2021
Radiographic outcome : - Brooker classification of heterotopic ossification
t was measured in October 2021
Subsidence
Time Frame: t was measured in October 2021
Radiographic outcome : - Subsidence: considered significant if more than 5 mm between the immediate postoperative x-ray and the last follow-up x-ray. Subsidence was assessed by measuring the distance between the tip of the trochanter and the "shoulder" of the stem
t was measured in October 2021
Stress shielding.
Time Frame: t was measured in October 2021
Radiographic outcome : we measured the rate of patients with Xray showing stress shielding signs
t was measured in October 2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hoel Letissier, MD, Chu de Brest

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 13, 2022

Primary Completion (Actual)

May 16, 2022

Study Completion (Actual)

May 16, 2022

Study Registration Dates

First Submitted

May 17, 2022

First Submitted That Met QC Criteria

June 29, 2022

First Posted (Actual)

July 5, 2022

Study Record Updates

Last Update Posted (Actual)

July 5, 2022

Last Update Submitted That Met QC Criteria

June 29, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PTHVarus ( 29BRC22.0081)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Arthritis

Clinical Trials on Total Hip Arthroplasty

Subscribe